HOME          Company Info          Press Releases          How To Get Test           Request Information          Comments/Suggestions


btastat.com

SEARCH SITE

Click here to
 learn more...

About Bladder Cancer

PATIENT
INFO

PHYSICIAN/
LAB
INFO

V-BTA
Canine Bladder Cancer Test

Other Bladder Cancer Info LINKS

The BTA TRAK® Assay

A Powerful New Quantitative Immunoassay 
for Monitoring Bladder Cancer Patients

Useful in Monitoring Patients for
Disease Progression and Recurrence

  • Accurate, non-invasive adjunct to cystoscopy

  • Superior sensitivity and specificity

  • Serial measurements may aid in detecting persistent disease following surgical or medical treatment for bladder cancer

  • The BTA TRAK Assay results may predict recurrence by detecting tumors not visualized by cystoscopy


Mean BTA TRAK Assay Values for Healthy Subjects and Bladder Cancer Patients
[Distribution of Bladder tumor antigen by disease state]

Disease Category Sample Size (n) Mean (U/mL)
Healthy Subjects 212 4.1
Active Bladder Cancer* 216 604
Stage: Tis 18 68
  Ta 108 317
  T1 38 851
  T2-4 50 1250
Grade: I 53 212
  II 56 543
  III 96 914
*(includes unknown stages/grades) 

 

 Product Info     Package Insert     References     Principle of The BTA statŪ Test     BTA TRAK Assay info